Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (4479)	6/12/1998 1:28:00 PM
From: scaram(o)uche	Read Replies (1) of 6136

Izzy: I see this deal as a "wait and see what the upside might be, while covering active immunotherapy". Margie has mentioned a renewed interest in active immunization. Let's see what this HAART data looks like before speculating about upside. Maybe that's not clear.... Johnson always tries to keep a step ahead of the next guy. I think he just took a "what if" away from those who might want access to his sales force. Nope, I don't have a grasp on revenues/earnings potential. One might picture something like a vaccine, a PI, and DMP-266. I'm not too focused. :-) If there's compelling data from the vaccine work with HAART.... it would be yet another step into eradicating part of the pain in the "S" of AIDS. Let's pray that we can start, near-term, to call it "ACIDS"..... acquired and chronic immune deficiency syndrome. Most of us live with herpes viruses that would kill us in the absence of active immunity. If active immunity can play a role in limiting pathogenicity, compliance issues would change. Life would get so much better, for so many. Go IMNR! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next